{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:03:52Z","timestamp":1779084232194,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI007245"],"award-info":[{"award-number":["AI007245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI07387"],"award-info":[{"award-number":["AI07387"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI078526"],"award-info":[{"award-number":["AI078526"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI096040"],"award-info":[{"award-number":["AI096040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1033091"],"award-info":[{"award-number":["OPP1033091"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ragon Institute of MGH, MIT, and Harvard"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.048","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T23:44:58Z","timestamp":1472168698000},"page":"4955-4963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization"],"prefix":"10.1016","volume":"34","author":[{"given":"Pablo","family":"Penaloza-MacMaster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quazim A.","family":"Alayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Ra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Provine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.048_b0005","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0010","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.02616-07","article-title":"Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys","volume":"82","author":"Liu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"key":"10.1016\/j.vaccine.2016.08.048_b0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1099\/vir.0.030064-0","article-title":"Coding potential and transcript analysis of fowl adenovirus 4: insight into upstream ORFs as common sequence features in adenoviral transcripts","volume":"92","author":"Griffin","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0025","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.048_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.048_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"Barouch","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.048_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.048_b0045","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"HIV-1 vaccines. Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.08.048_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2016.08.048_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2016.05.011","article-title":"New concepts in HIV-1 vaccine development","volume":"41","author":"Stephenson","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0080","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.048_b0085","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2016.08.048_b0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0095","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.08.048_b0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.048_b0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellimm.2004.09.004","article-title":"PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells","volume":"230","author":"Cai","year":"2004","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0110","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.08.048_b0115","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0120","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0125","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.08.048_b0130","first-page":"916936","article-title":"Elevation of Tim-3 and PD-1 expression on T cells appears early in HIV infection, and differential Tim-3 and PD-1 expression patterns can be induced by common gamma -chain cytokines","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2016.08.048_b0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3892\/br.2014.217","article-title":"Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection","volume":"2","author":"Wang","year":"2014","journal-title":"Biomed Rep"},{"key":"10.1016\/j.vaccine.2016.08.048_b0140","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/eji.201040340","article-title":"HCV-specific T cells in HCV\/HIV co-infection show elevated frequencies of dual Tim-3\/PD-1 expression that correlate with liver disease progression","volume":"40","author":"Vali","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0145","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity","volume":"120","author":"McMahan","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2016.08.048_b0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/acel.12435","article-title":"Characterization of age-associated exhausted CD8(+) T cells defined by increased expression of Tim-3 and PD-1","volume":"15","author":"Lee","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.vaccine.2016.08.048_b0155","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"Fourcade","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.08.048_b0160","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.08.048_b0165","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2012-04-421826","article-title":"High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells","volume":"121","author":"Myklebust","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2016.08.048_b0170","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0175","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/JVI.78.11.5535-5545.2004","article-title":"Memory CD8 T-cell differentiation during viral infection","volume":"78","author":"Wherry","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.smim.2004.08.013","article-title":"Generation and maintenance of immunological memory","volume":"16","author":"Gourley","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0190","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.4049\/jimmunol.179.10.6704","article-title":"Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation","volume":"179","author":"Sarkar","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.048_b0195","first-page":"6704","article-title":"Comparative analysis of SIV Gag specific effector and memory CD8 T cells induced by different adenovirus vectors","volume":"179","author":"Tan","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.048_b0200","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2016.08.048_b0205","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2011.05.083","article-title":"Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines","volume":"29","author":"Pillai","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.048_b0210","first-page":"1","article-title":"Hexon hypervariable region-modified adenovirus 5 vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors","author":"Teigler","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:39:38Z","timestamp":1565379578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":42,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307332"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}